000			02003 a2200529 4500
005			20250516193019.0
264		0	_c20150622
008			201506s 0 0 eng d
022			_a1520-7560
024	7		_a10.1002/dmrr.2525 _2doi
040			_aNLM _beng _cNLM
100	1		_aForst, Thomas
245	0	0	_aEffect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment. _h[electronic resource]
260			_bDiabetes/metabolism research and reviews _cOct 2014
300			_a582-9 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aCardiovascular Diseases _xepidemiology
650	0	4	_aDiabetes Mellitus, Type 2 _xcomplications
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlucagon _xblood
650	0	4	_aGlucagon-Like Peptide 1 _xblood
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xpharmacology
650	0	4	_aInsulin _xblood
650	0	4	_aIslets of Langerhans _xdrug effects
650	0	4	_aLinagliptin
650	0	4	_aMale
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPlasminogen Activator Inhibitor 1 _xblood
650	0	4	_aPostprandial Period _xphysiology
650	0	4	_aProinsulin _xblood
650	0	4	_aPurines _xpharmacology
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aRisk Factors
650	0	4	_aSulfonylurea Compounds _xpharmacology
700	1		_aAnastassiadis, Ernestos
700	1		_aDiessel, Stephan
700	1		_aLöffler, Andrea
700	1		_aPfützner, Andreas
773	0		_tDiabetes/metabolism research and reviews _gvol. 30 _gno. 7 _gp. 582-9
856	4	0	_uhttps://doi.org/10.1002/dmrr.2525 _zAvailable from publisher's website
999			_c23481122 _d23481122